Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Neuroblastoma × Lenalidomide × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 237 Lymphoma, Large B-Cell, Diffuse 59 Leukemia, Lymphocytic, Chronic, B-Cell 59 Neoplasms, Plasma Cell 44 Lymphoma, Follicular 42 Lymphoma, Mantle-Cell 39 Lymphoma 38 Recurrence 35 Lymphoma, B-Cell, Marginal Zone 31 Leukemia 28 Leukemia, Myeloid, Acute 25 Lymphoma, B-Cell 18 Myelodysplastic Syndromes 16 Waldenstrom Macroglobulinemia 15 Lymphoma, Non-Hodgkin 15 Smoldering Multiple Myeloma 12 Hodgkin Disease 12 Lymphoma, T-Cell, Peripheral 10 Neoplasms 9 Prostatic Neoplasms 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Lymphoma, T-Cell, Cutaneous 8 Immunoglobulin Light-chain Amyloidosis 8 Burkitt Lymphoma 8 Sezary Syndrome 7 Mycosis Fungoides 7 Neoplasm, Residual 6 Lymphoma, T-Cell 6 Lymphoma, Large-Cell, Anaplastic 6 Intraocular Lymphoma 6

Interventions

Cyclophosphamide 47 Etoposide 27 Irinotecan 25 Temozolomide 24 Melphalan 24 3-Iodobenzylguanidine 22 Topotecan 20 Filgrastim 20 Isotretinoin 19 Carboplatin 18 Granulocyte Colony-Stimulating Factor 16 sargramostim 15 fludarabine 15 Granulocyte-Macrophage Colony-Stimulating Factor 15 humanized 3F8 anti-GD2 monoclonal antibody 14 dinutuximab 13 Peripheral Blood Stem Cell Transplantation 13 Doxorubicin 13 Cisplatin 13 Radiotherapy 12 Interleukin-2 12 Busulfan 12 naxitamab 11 Vincristine 11 fludarabine phosphate 10 aldesleukin 9 Thiotepa 9 Eflornithine 8 Vorinostat 7 Stem Cell Transplantation 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04049864 2022-03-02

DNA Vaccination Against Neuroblastoma

Belarusian Research Center for Pediatric Oncology, Hematology and Immunology

Phase EARLY_PHASE1 Unknown

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡